Skip to main content
. Author manuscript; available in PMC: 2006 Oct 1.
Published in final edited form as: Am J Physiol Regul Integr Comp Physiol. 2005 Jun 9;289(4):R1048–R1053. doi: 10.1152/ajpregu.00312.2005

Fig. 5.

Fig. 5

Survival curve of mice that received either 1.33 mg/kg or 2.66 mg/kg anti-IL-6 antibody or control IgG beginning 6 hours following CLP. Monoclonal therapy directed against IL-6 does not alter survival when initiated at this timepoint.